Abstract
Purpose:
To assess the Support, Educate, Empower (SEE) personalized glaucoma coaching program impact on (1) eye drop instillation technique and (2) eye drop instillation self-efficacy.
Design:
Prospective pre–post pilot study.
Participants:
Patients with a diagnosis of glaucoma or ocular hypertension taking 1 or more glaucoma medications who were 40 years of age or older, spoke English, self-administered their eye drops, and were 80% or less adherent to their glaucoma medication by electronic monitoring.
Methods:
Eye drop administration was video recorded before the first SEE in-person coaching session, which included teaching eye drop instillation techniques using a motivational interviewing-based approach. At the third and final in-person counseling session 6 months later, eye drop administration was video recorded. Participants’ self-efficacy was assessed using the validated Eye Drop Technique Self-Efficacy Scale (EDTSES) survey at baseline and 1 month after completion program. Before and after intervention videos were assessed by an observer masked to time point. Before versus after intervention comparisons were made using McNemar’s and paired t tests.
Main Outcome Measures:
The main outcome was change in participants’ eye drop instillation technique as measured by (1) accuracy of an eye drop landing on the eye, (2) ability to instill an eye drop on the first attempt, and (3) contaminating the bottle by contact with ocular surface, eyelashes, and skin. The secondary outcome measure was before versus after change in the EDTSES score (6 items, each assessed on a 3-point Likert scale, with higher scores indicating better self-efficacy).
Results:
Thirty-nine participants completed the SEE intervention, 38 with before and after EDTSES scores and 31 with video recordings. Six of 31 participants instilling drops outside the eye before intervention improved their technique after intervention, whereas 2 participants worsened (P = 0.157). From before to after intervention, participants demonstrated significant improvement in not touching the ocular surface (P = 0.046), the eyelashes (P = 0.020), or the skin (P = 0.025) with the bottle tip. A significant increase was found in eye drop instillation self-efficacy from an average score of 2.6 (standard deviation [SD], 0.3) to 2.8 (SD, 0.2) on the EDTSES score (P = 0.007).
Conclusions:
The SEE program significantly decreased eye drop bottle contamination and increased eye drop instillation self-efficacy.
Keywords: Adherence to eye drops, Eye drop adherence, Eye drop instillation, Eye drop instillation technique, Eye drop technique, Motivational interviewing, Personalized coaching program
Correct eye drop instillation is a critically important and modifiable component of effective glaucoma medication use. Even if a patient maintains a strict adherence schedule, it is for naught if eye drop instillation technique is poor. Previous studies show that one quarter of patients’ attempts to instill drops miss the eye entirely.1,2 Between 20% and 80% of patients contaminate the eye drop bottle by contacting the ocular surface, adnexa, or face.3,4 As a result of poor self-administration technique, these patients are more likely to experience substantial glaucomatous vision loss5,6 that can lead to decreased quality of life7–9 and increased risk for traumatic events such as falls or motor vehicle accidents.10 Therefore, this study was designed to assess a new method to teach eye drop instillation technique.
Educational tactics, mechanical devices, and reminder interventions designed to improve eye drop application have been assessed independently and reported in the literature, with widely varying results.11–16 Promising results for reduction in contamination have been shown with some medical devices, but devices present additional challenges to patients, including access, correct use, and overall usability.15,38 Generally, multifaceted approaches have shown the most promise for improving eye drop instillation technique. In one study, participants viewed an instructional video and a diagram, and in another study, participants were video recorded while self-instilling drops and then received constructive feedback from their physician.18,19 Outcomes using these approaches were promising. However, the outcomes were measured directly after the intervention on the same day. These studies did not examine whether the patient continued to demonstrate longer-term competence or improved self-efficacy, both important considerations for successful medication adherence in a chronic disease like glaucoma.20
Personalized counseling interventions are multifaceted, go beyond technique instruction alone, and have promise in improving patient self-efficacy and skills to overcome barriers to adherence.21–23 Counseling based on motivational interviewing (MI), a patient-centered approach that helps people to explore personal motivations for positive health behaviors, has been found to be very effective in improving adherence to medication regimens in conditions such as diabetes and hypertension.24–28 To our knowledge, no studies to date have measured objectively the impact of using personalized MI-based counseling to teach eye drop instillation. The purpose of this pilot study was to evaluate if using an MI-based approach to teach eye drop instillation as part of the Support, Educate, Empower (SEE) personalized glaucoma coaching program improved: (1) the accuracy of an eye drop landing on the eye, (2) the ability to instill an eye drop on the first attempt, and (3) the ability to avoid contaminating the bottle. We additionally assessed whether patient self-efficacy related to instillation of eye drops changed after participating in the SEE program.
Methods
Study Sample
The SEE program was a 7-month personalized glaucoma coaching program whose overarching aim was to improve glaucoma medication adherence. Recruitment for the SEE program took place at the main tertiary care eye center at the University of Michigan and all 10 satellite ophthalmology clinics. Eligible patients included those who had a glaucoma diagnosis (including glaucoma suspect and ocular hypertension), were 40 years of age or older, took 1 or more glaucoma medication, and spoke English. These patients were sent a letter with an option to opt out of recruitment. Those who had a diagnosis of a severe mental illness (defined as a diagnosis of bipolar disorder, schizophrenia, or depressive episode with psychosis) or cognitive impairment (defined as a diagnosis of dementia or memory loss) were excluded from the study. Individuals who met these inclusion and exclusion criteria were called, and if interested in study participation, they were administered 2 validated scales assessing medication adherence and were questioned about whether they instilled their own eye drops. The Chang Adherence Measure is a single-item assessment of glaucoma medication adherence that asks, “Over the past month, what percentage of your drops do you think you took correctly?” The Morisky Medication Adherence Scale is an 8-item medication adherence scale in which a higher score represents better adherence. Those who self-reported adherence of less than 95% on the Chang Adherence Measure29 had a score of 6 or less on the Morisky Medication Adherence Scale30 and who self-instilled eye drops were invited to undergo a 3-month baseline monitoring period during which glaucoma medication adherence was measured with electronic monitors (AdhereTech, New York, NY).7,31 Forty-eight patients (51% of the 95 who completed monitoring) showed a baseline adherence score of 80% or less and were deemed eligible for the SEE program intervention. Thirty-nine of the 48 eligible participants completed the 7-month SEE program. The 38 participants completed the Eye Drop Technique Self-Efficacy Scale (EDTSES) at baseline and then again 1 month after the glaucoma counseling program had ended. Before and after intervention video recordings of participants self-administering eye drops were obtained for 31 of these participants. Data were missing because some videos were obtained only before (n = 3) or after (n = 3) the intervention because of errors in uploading the video to the secure storage server, and some videos were lost because of technological error (n = 2). A detailed overview of participant study flow is presented in Figure 1. The SEE program pilot study (ClinicalTrials.gov identifier, NCT03159247) was approved by the University of Michigan Institutional Review Board and adhered to the tenets of the Declaration of Helsinki.
Figure 1.
Flow diagram for study population showing the number of participants at exclusion points and the number of participants lost to followup. The numbers of participants are included for each point of dropout. EDTSES = Eye Drop Technique Self-Efficacy Scale; SEE = Support, Educate, Empower.
Support, Educate, Empower Program
The SEE program was designed to address and improve patient eye drop adherence using team-based care, wherein a trained health coach uses an eHealth tool (www.glaucomaeyeguide.org) to deliver personalized glaucoma education and counseling. The SEE program is a personalized glaucoma counseling program focused on improving all aspects of glaucoma medication adherence, including the ability to instill eye drop medications accurately and effectively.21 In brief, the SEE program consisted of 8 meetings between a trained glaucoma counselor and the participant (3 in-person meetings and 5 between-visit phone calls for follow-up support). The educational material in the SEE program is personalized through a web-based tool so that the counselor can offer education about the participant’s particular glaucoma diagnosis, test results, doctor’s recommendations, and barriers to optimal medication adherence. The counselor uses MI-based counseling to identify the patient’s specific barriers to adherence and to brainstorm constructive solutions collaboratively. The SEE program is described in detail in a previous publication.21
Eye Drop Technique Instruction
During the first in-person counseling sessions, the glaucoma counselor used the SEE web-based personalized educational tool to teach the participant about eye drop instillation. Participants could choose to go over eye drop instillation again with the coach at the second and third in-person visit if they wanted to; all participants chose to go over eye drop instillation again at the second in-person visit and none of the participants chose to go over it at the third visit. Eye drop instillation was taught using an elicit-provide-elicit method of communication. Elicit-provide-elicit is a component of MI that establishes what the patient already knows by asking the patient to demonstrate how they instill the eye drops, asks permission to provide advice, shows 2 new ways of instilling eye drops through a visual display, and then asks the patient to demonstrate their new eye drop instillation technique to see whether and how the new information has helped them. The information the counselor provided on how to instill eye drops was based on national guidelines and included important points such as hand washing, contamination prevention, and accurate delivery of a single drop to the eye.32 Visuals and prompts for common challenges to proper technique were included onsite for the counselor and participant to work through together (Fig 2). Participants were given access to the eye drop instructional materials after the counseling session through both a printed handout and a login and password for the website to access the web-based materials.
Figure 2.
Screenshot showing the eye drop instillation guide on the Support, Educate, Empower program web-based tool. The step-by-step eye drop instillation guide is for counselors to use during the in-person participant sessions and for participants to access independently outside of the clinic. Icons R, Q, P provide drop-down prompts useful for the counselor to elicit participant perspective and to individualize each session.
Assessments
Participant eye drop instillation was video recorded before and after the intervention. The before intervention video was recorded before any instruction was given during the first in-person coaching session. After eye drop instillation was video recorded, the eye drop instillation coaching was given. Two months later, participants went through the eye drop instillation coaching again as part of the second coaching session. Two months later at the 6-month visit, the after intervention video was recorded after the final in-person coaching session. No participants received eye drop instillation coaching at this session. Videos were recorded for both eyes of a participant and for as many attempts as participants made, although correct instillation of eye drops was not always achieved.
One trained investigator masked to time point analyzed all videos and scored each participant’s eye drop technique according to the techniques of Hennessy et al.33 Eye drop technique was scored as follows: number of attempts to instill 1 eye drop in the eye correctly, location of first drop attempt (ocular surface, eyelid, canthus, skin surrounding the eye), number of drops instilled into eye, and touch between the bottle tip and the ocular surface, eyelashes, or skin. The primary outcome was determining if the intervention produced change in participants’ eye drop instillation techniques as measured by (1) accuracy of an eye drop landing on the ocular surface (as opposed to skin outside the eye), (2) ability to instill an eye drop on the first attempt, and (3) contaminating the bottle by contact with the ocular surface, eyelashes, or skin outside of the eye. If an eye drop landed partially in and outside of the eye, it was considered to be outside the eye.
At the baseline study visit before the SEE counseling program, participants completed a questionnaire that included the EDTSES. The EDTSES is a 6-item scale developed and validated in conjunction with the 10-item Glaucoma Adherence Self-Efficacy Scale (Cronbach’s α, 0.91 for all 14 items) that assesses participants’ self-confidence in their ability to administer their eye drops.34,35 The EDTSES assesses eye drop self-efficacy using 6 items asking about participant confidence with instilling their eye drops, each scored on a 3-point Likert scale from 1 (not at all confident), to 2 (somewhat confident), to 3 (very confident).34 The scale is scored as a mean of the 6-item responses, with higher scores indicating higher self-efficacy. The EDTSES was administered again as part of a survey 1 month after completion of the SEE program.
Statistical Analysis
Demographic characteristics of the participant sample were summarized with descriptive statistics including means, standard deviations (SDs), frequencies, and percentages. Eye drop technique accuracy and contamination measures were aggregated to the participant-level by using the worse application between eyes on the first instillation attempt. For example, if a participant contaminated the bottle tip by touching the ocular surface in one eye and not the other eye on the first instillation attempt, the participant would be classified as contaminating the bottle tip to the ocular surface. The ability to instill an eye drop on the first attempt was measured by using the best attempt in either eye. The number of attempts needed to instill an eye drop to the eye correctly was measured by looking at the minimum number of attempts made to instill the eye drop in either eye correctly. Change in these measures was assessed using McNemar chi-square tests for paired data.
The mean EDTSES scores from before and after the SEE program were compared using a paired t test. Individual responses to the 6 items of the EDTSES also were compared before and after the SEE intervention using McNemar chi-square tests for paired data. For this analysis, individual questions on the EDTSES were collapsed into 2 categories: not at all confident or somewhat confident and very confident, because very few participants reported being not at all confident across all survey questions (Table S1, available at www.ophthalmologyglaucoma.org).
The association between change in EDTSES score and change in accuracy of video recorded eye drop technique before to after intervention also was assessed. Each eye drop technique outcome measure (accuracy, instilled eye drop correctly on first attempt, and contamination) was categorized for the change observed from before to after SEE program intervention. These changes were categorized as follows: improvement in technique, not proficient before intervention and proficient after intervention; worsening technique, proficient to not proficient; proficient, no change in technique, where proficient at both times before and after intervention; and not proficient, no change in technique, where not proficient at both times before and after intervention. Mean EDTSES scores changes were compared between these accuracy change groups using the analysis of variance when the number of groups was more than 2 and using t tests when the number of groups was 2. All analyses were performed with SAS software version 9.4 software (SAS Institute, Carey, NC).
Results
Table 1 shows the demographics of the participant sample for both those who completed EDTSES surveys and those who completed instillation videos and EDTSES surveys. A total of 38 participants completed the SEE program and the baseline and intervention-end EDTSES. Of the 38 participants, 45% (n = 17) were women, 43% (n = 16) were White, 8% (n = 3) had less than a high school education, and 24% (n = 8) reported a yearly income of less than $25 000 per year. On average, participants were 64 years of age (SD, 10.8 years). Thirty-one participants completed both the before and after video analyses. The 31 participants represented a similar range of demographic characteristics: 42% (n = 13) were women, 40% (n = 12) were White, 10% (n = 3) had less than a high school education, and 21% (n = 6) reported a yearly income of less than $25 000 per year. On average, the 31 participants were 62 years of age (SD, 10.7 years). No significant demographic differences were found between the participants who completed the EDTSES survey and instillation videos (n = 31) and the participants who did not complete instillation videos (n = 7).
Table 1.
Demographic Characteristics of Sample Participants
| Demographic Characteristics | Completed Instillation Videos and Eye Drop Technique Self-Efficacy Scale Survey (n [ 31) | Completed Eye Drop Technique Self-Efficacy Scale Survey (n [ 38) |
|---|---|---|
| Age (yrs), mean (SD) | 62 (10.7) | 64 (10.8) |
| Race, no. (%) | ||
| No. missing | 1 | 1 |
| White | 12 (40) | 16 (43) |
| Black | 15 (50) | 18 (49) |
| Other | 3 (10) | 3 (8) |
| Gender, no. (%) | ||
| Male | 18 (58) | 21 (55) |
| Female | 13 (42) | 17 (45) |
| Education, no. (%) | ||
| Less than high school | 3 (10) | 3 (8) |
| High school diploma | 4 (13) | 4 (11) |
| Some college | 10 (32) | 12 (32) |
| College degree | 5 (16) | 8 (21) |
| Graduate degree | 9 (29) | 11 (29) |
| Income ($), no. (%) | ||
| No. missing | 3 | 4 |
| <25 000 | 6 (21) | 8 (24) |
| 25 000–50 000 | 12 (43) | 14 (41) |
| 51 000–100 000 | 7 (25) | 7 (21) |
| >100 000 | 3 (11) | 5 (15) |
SD = standard deviation.
Accuracy of Instilling Eye Drops in the Eye
Six (19%) participants’ eye drop instillation accuracy improved after the program: they instilled an eye drop outside of the eye before intervention, but not after intervention (P = 0.157; Table 2). Conversely, 2 (6%) participants’ eye drop instillation accuracy worsened after the program because of instilling an eye drop inside the eye before intervention but not doing so after intervention. The remaining participants showed no change in eye drop installation accuracy; 6 (19%) instilled the eye drop outside the eye at both time points and 17 (55%) instilled the eye drop correctly at both time points.
Table 2.
Video-Recorded Eye Drop Installation Accuracy and Contamination before Intervention and after Intervention
| Remained the Same |
|||||
|---|---|---|---|---|---|
| Outcome | Not Proficient | Proficient | Improved* | Worsened* | P Value† |
| Drop instilled | |||||
| Outside the eye | 6 (19) | 17 (55) | 6 (19) | 2 (6) | 0.157 |
| On first attempt | 0 (0) | 24 (77) | 2 (6) | 5 (16) | 0.257 |
| Bottle contamination | |||||
| With ocular surface | 0 (0) | 27 (87) | 4 (13) | 0 (0) | 0.046 |
| With eyelashes | 0 (0) | 22 (71) | 8 (26) | 1 (3) | 0.020 |
| With skin | 0 (0) | 26 (84) | 5 (16) | 0 (0) | 0.025 |
Data are frequency (%) unless otherwise indicated.
”Worsened” denotes individuals who were proficient at the particular skill before intervention but not after intervention, and “Improved” denotes individuals who were not proficient at the particular skill before intervention but were after intervention.
McNemar’s test for paired data.
Number of Attempts Needed to Instill an Eye Drop
During the video recording before intervention, 26 of 31 participants (84%) needed just 1 attempt to place the eye drops into either of the eyes, 2 (6%) needed 2 attempts, 1 (3%) needed 3 attempts, and 2 (6%) did not place the drop into the eyes at all. In the recordings after the intervention, 29 of 31 participants (94%) needed only 1 attempt to place the eye drops into either eye, and 2 participants (6%) needed 2 attempts, but still did not instill a drop into the eye. No participant dispensed more than 1 drop on any single attempt. Five participants (16%) were not able to instill an eye drop on the first attempt before the SEE intervention, but were able to after the SEE intervention. The technique of 2 participants (6%) worsened after the SEE program: they instilled an eye drop on the first attempt before intervention and were not able to do so after the intervention (P = 0.257). The remaining participants (n = 24 [77%]) successfully instilled a single drop in the eye both before and after intervention (Table 2).
Bottle Contamination
All assessments of bottle contamination improved significantly after participating in the SEE program. Four participants (13%) touched the bottle tip to the ocular surface before intervention, but did not after intervention. No participants demonstrated the converse by not touching the ocular surface before the program and contaminating the bottle tip after the SEE program (P = 0.046; Table 2). Eight participants (26%) touched the bottle tip to the eyelashes before the intervention, but did not do so after the intervention, whereas 1 participant (3%) did not touch the eyelashes before the intervention, but did so after the intervention (P = 0.020; Table 2). Five participants (16%) touched the bottle tip to their skin before the intervention, but did not do so after the intervention. No participants showed a worsening of behavior by not contaminating the bottle tip by touching the skin before the program, but contaminating the bottle tip after the SEE program (P = 0.025; Table 2).
Eye Drop Technique Self-Efficacy Scale
The average score on the EDTSES increased significantly from 2.6 (SD, 0.3) at baseline to 2.8 (SD, 0.2) after the intervention (P = 0.001; Table 3). When analyzing each individual item from the EDTSES, confidence in “consistently getting the right amount of eye drop medication in your eye each time you use it” (EDTSES question 3; P = 0.021), and “delivering the required amount of eye drops to the eye without missing or applying too much medication” (EDTSES question 5; P = 0.003) showed the largest percentage of participants reporting improved confidence after the intervention. None of the other questions showed significant improvements before or after the intervention.
Table 3.
Eye Drop Technique Self-Efficacy Scale Scores before and after Intervention
| Remained the Same |
|||||
|---|---|---|---|---|---|
| Question: How Confident Are You That You Can Carry out the Following Tasks? | Confident | Not Confident | Improved* | Worsened* | P Value |
| 1. Squeezing your eye drop bottle | 35 (95) | 0 (0) | 2 (6) | 0 (0) | 0.157 |
| 2. Placing the medication drop(s) in your eye | 29 (76) | 0 (0) | 7 (19) | 2 (5) | 0.096 |
| 3. Consistently placing the right amount of eye drop medication in your eye each time | 12 (33) | 12 (33) | 10 (28) | 2 (6) | 0.021 |
| 4. Correctly angling your head to apply eye drop(s) accurately | 19 (51) | 3 (8) | 11 (30) | 4 (11) | 0.071 |
| 5. Delivering the required amount of your eye drop(s) to the eye without missing or applying too much | 10 (26) | 12 (32) | 14 (37) | 2 (5) | 0.003 |
| 6. Not touching your eye with the eye drop bottle | 21 (55) | 5 (13) | 7 (18) | 5 (13) | 0.564 |
| EDTSES mean score (SD) | Before intervention, 2.6 (0.3) | After intervention, 2.8 (0.2) | 0.001 | ||
EDTSES = Eye Drop Technique Self-Efficacy Scale; SD = standard deviation.
Data are frequency (%) unless otherwise indicated. Individual questions were analyzed using McNemar’s test, and the overall EDTSES mean score was analyzed using a paired t test. Not all participants answered every question. The EDTSES responses were collapsed into 2 categories for individual questions.
“Worsened” denotes individuals who were confident before intervention but not after intervention, and “Improved” denotes individuals who were not confident before intervention but were confident after intervention.
Relationship between Eye Drop Instillation Technique and Eye Drop Technique Self-Efficacy Scale Score
Table 4 shows the average change in mean EDTSES score from before to after SEE program intervention by categorical change in each eye drop instillation accuracy change measure. Although no significant differences were found in mean EDTSES score across groups for any of the eye drop instillation accuracy or bottle tip contamination measures, the trends were nearly all in the appropriate directions, demonstrating an association between the improvement in EDTSES score and the improved eye drop instillation behavior. For example, for those whose technique improved and who no longer instilled an eye drop outside the eye after the SEE program (n = 6), their EDTSES score increased by 0.06 (SD, 0.5). Conversely, for those whose technique worsened after the SEE program and who instilled a drop only outside the eye after the program (n = 2), the EDTSES score decreased by 0.08 (SD, 0.6; Table 4). The only category for which the trend was in the opposite direction was the assessment of whether participants were able to instill an eye drop into the eye on the first attempt. The EDTSES score decreased (e0.03) for those whose accuracy improved (n = 2; SD, 0.3) and the EDTSES score increased (0.17) for those whose accuracy worsened (n = 5; SD, 0.2; Table 4).
Table 4.
Change in Eye Drop Self-Efficacy Scale Scores by Change in Eye Drop Instillation Measures before to after Intervention
| Before to after Video Accuracy Variables | No. | Change in Eye Drop Self-Efficacy Scale Score, Mean (Standard Deviation) | P Value* |
|---|---|---|---|
| Instilled eye drop outside of eye | |||
| Improved technique | 6 | 0.06 (0.5) | |
| Worsened technique | 2 | −0.08 (0.6) | |
| Proficient, no change in technique | 17 | 0.26 (0.3) | |
| Not proficient, no change in technique | 6 | 0.17 (0.2) | 0.437 |
| Instilled eye drop on first attempt | |||
| Improved technique | 5 | −0.03 (0.3) | |
| Worsened technique | 2 | 0.17 (0.2) | |
| Proficient, no change in technique | 24 | 0.24 (0.4) | 0.328 |
| Contaminated bottle tip with ocular surface | |||
| Improved technique | 4 | 0.13 (0.3) | 0.739 |
| Proficient, no change in technique | 27 | 0.19 (0.4) | |
| Contaminated bottle tip with eyelashes | |||
| Improved technique | 8 | 0.08 (0.4) | |
| Worsened technique | 1 | −0.17 (.) | |
| Proficient, no change in technique | 22 | 0.23 (0.3) | 0.311 |
| Contaminated bottle tip with skin | |||
| Improved technique | 5 | 0.03 (0.4) | 0.310 |
| Proficient, no change in technique | 26 | 0.21 (0.3) | |
Difference in the Eye Drop Technique Self-Efficacy Scale score was calculated from before to after intervention.
An analysis of variance was performed for all variables with more than 2 categories and sample sizes of more than 1. A t test was performed for all variable with only 2 categories.
Discussion
After completing the 7-month SEE program, the 31 participants demonstrated a significant decrease in bottle tip contamination and a significant improvement in eye drop instillation self-efficacy. Participants’ confidence in delivering the correct amount of medication—neither too much nor too little—showed the most improvement of all the self-efficacy items after SEE program participation. Participants also demonstrated improved accuracy of eye drop instillation (the drop landing outside the eye vs. on the ocular surface): 6 (19%) improved whereas only 2 (6%) worsened (P = 0.157). Additionally, after SEE program participation, 5 participants (16%) improved in their ability to instill an eye drop on the first attempt compared with 2 participants (6%) whose instillation technique worsened (P = 0.257).
In a nationwide study of 279 doctor—glaucoma patient interactions, the frequency and type of eye drop instillation education given was assessed, and the investigators found that only 31% of patients received verbal education and 10% received visual education. The visual education involved either the provider watching the patient instill the eye drops or the patient watching the provider instill eye drops. None of this education had an impact on eye drop instillation technique 8 months later.36 In contrast, our study highlights the potential benefit of a standardized yet personalized educational approach to teaching eye drop instillation.
In light of a nationwide push for medical institutions to be more scrupulous with resources, a need exists to assess whether in-person education or counseling adds value over paper-based or web-based education, because not all educational interventions are effective for improving eye drop technique.13,14,18,19 McVeigh and Vakros14 demonstrated that instructional charts alone can improve patient hand hygiene in preparation for instilling eye drops. However, they showed no improvement for instilling 1 eye drop to the eye on first attempt or for preventing contamination. Patients who struggled with the chart described it as difficult to read, interpret, and apply to their own technique. Results from studies using video education show promise. Feng et al19 reported improvement in average eye drop technique, but showed no reduction in contamination after the combined educational video and chart intervention. A recent randomized control trial by Davis et al37 included a 4-minute glaucoma eye drop technique educational video. Technique was defined as a single variable ranging from 0 to 5, with 5 total steps, including instilling a single drop, holding the eye lid open with fingers, placing 1 drop accurately onto the eye, not touching the bottle tip to the eye or face, and closing the eye for 1 minute after instillation. Significant improvement in technique was found immediately after the video and 1 month later.
Educational videos can play a pivotal role in improving eye drop technique, but a one-size-fits-all approach will not work for patients who struggle with audio-visual materials or who do not realize they are instilling the drops incorrectly.33 One study highlighted how one-on-one interaction can allow for remediation of technique.18 Patients were recorded self-administering eye drops and then patients viewed the video with their physician, received instruction on how to improve technique, and made a renewed attempt at instilling the eye drops correctly. Before and after video analysis in the study demonstrated positive results with improved accuracy and reduced contamination directly after the intervention.18 In the present study, in which our intervention included standardized, yet personalized, inperson coaching by a glaucoma counselor, contamination clearly improved even months from the eye drop instillation coaching session. To our knowledge, the SEE program is the first intervention to demonstrate lasting technique change months after the intervention.
Patient self-efficacy, measured by the EDTSES, is the belief that one is able to instill eye drops appropriately. High self-efficacy is a positive predictor for both glaucoma medication adherence and accurate eye drop technique.38 In the present study, mean EDTSES scores increased significantly (P = 0.007) after the SEE intervention. Dreer et al39 recently conducted a prospective pilot study of a 4-week personalized counseling intervention based on MI techniques and demonstrated a 15-percentage point increase in electronically monitored adherence and a significant increase in self-efficacy (P = 0.02) among the 11 participants. Our studies are complementary in that MI-based interactions increased self-efficacy for glaucoma medication adherence and self-efficacy for eye drop instillation.
Although an important predictor for success, confidence in eye drop technique does not always translate into quality self-application.40,41 For example, in one study, 91% of patients felt confident in their ability to instill eye drops correctly, but 29% still touched the dropper to the eye or skin.19 In the 2016 study by Sayner et al,42 patient characteristics and self-efficacy were examined in association with eye drop technique. They found self-efficacy to have no association with eye drop technique. In contrast, we noted that EDTSES scores trended in the correct direction among participants whose eye drop instillation technique improved from before to after the SEE program. For those who contaminated the bottle tip before the SEE program but did not do so afterward, the average EDTSES score increased. Participants who instilled an eye drop outside the eye before the SEE program and improved technique after the program showed an average EDTSES score increase. However, the EDTSES scores did not trend in the correct direction for the assessment of whether eye drops were instilled on the first attempt. For example, among the 5 participants who did not instill an eye drop on first attempt before the SEE program but did so afterward, the EDTSES score decreased on average, whereas the 2 patients whose accuracy decreased showed an average increase in the EDTSES score. We hypothesize that the EDTSES did not trend in the correct direction for this objective assessment of eye drop technique because the EDTSES does not ask directly about placing an eye drop into the eye in only 1 attempt.
The strengths of this study include the rigor of its methods and the assessment of technique before and after intervention. The study also had multiple limitations. As a pilot study, it was exploratory and not powered to detect change in any of the eye drop instillation outcomes. The small sample size precluded us from conducting a full analysis of potential confounders for change in eye drop technique such as visual acuity, visual field loss, presence of comorbidities, or handedness. The small sample size also precluded an evaluation of eye drop instillation success compared with success with medication adherence overall. Video recording also can invoke anxiety in some patients, potentially compromising the eye drop technique. Furthermore, video recording the outcomes of eye drop instillation does not capture fully the differences in physical technique that lead to these differences in outcome. Future work should quantify differences in technique more fully so that the interventions can be tailored better to each individual’s needs. Despite these limitations, this study demonstrated pilot evidence of efficacy in the use of the MI-based SEE counseling program to improve eye drop technique and patient eye drop technique self-efficacy. These results lay the groundwork for a future randomized controlled trial of the efficacy of the SEE program in improving medication adherence and eye drop instillation technique.
Supplementary Material
Acknowledgments
Financial Disclosure(s):
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Supported by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant no.: K23EY025320 [P.A.N.-C.]); and Research to Prevent Blindness, Inc., New York, New York (Career Development Award [P.A.N.-C.]). The funding organizations had no role in the design or conduct of this research.
HUMAN SUBJECTS: Human subjects were included in this study. The human ethics committees at the University of Michigan Institutional Review Board approved the study. All research adhered to the tenets of the Declaration of Helsinki.
No animal subjects were included in this study.
Personalized motivational interviewing-based eye drop instillation coaching through the Support, Educate, Empower program demonstrated increased participant self-efficacy for eye drop installation and decreased frequency of bottle contamination.
Abbreviations and Acronyms:
- EDTSES
Eye Drop Technique Self-Efficacy Scale
- MI
motivational interviewing
- SD
standard deviation
- SEE
Support
- Educate
Empower
Footnotes
Supplemental material available at www.ophthalmologyglaucoma.org.
References
- 1.Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence. 2011;5:441–463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Davies IJ, Brown NH, Wen JC, et al. An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle. Clin Ophthalmol. 2016;10: 1411–1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gupta R, Patil B, Shah BM, et al. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21:189–192. [DOI] [PubMed] [Google Scholar]
- 4.Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29: 1515–1522. [DOI] [PubMed] [Google Scholar]
- 5.Newman-Casey PA, Shtein RM, Coleman AL, et al. Why patients with glaucoma lose vision: the patient perspective. J Glaucoma. 2016;25:e668–e675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Susanna R, De Moraes CG, Cioffi GA, et al. Why do people (still) go blind from glaucoma? Transl Vis Sci Technol. 2015;4:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118: 2398–2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Quaranta L, Riva I, Gerardi C, et al. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33: 959–981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rulli E, Quaranta L, Riva I, et al. Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study. Sci Rep. 2018;8:619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gracitelli CPB, Tatham AJ, Boer ER, et al. Predicting risk of motor vehicle collisions in patients with glaucoma: a longitudinal study. PLoS One. 2015;10:e0138288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Davis SA, Sleath B, Carpenter DM, et al. Drop instillation and glaucoma HHS Public Access. Curr Opin Ophthalmol. 2018;29:171–177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Waterman H, Evans JR, Gray TA, et al. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev. 2013. April 30;(4):CD006132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Al-Busaidi A, Samek D, Kasner O. Eye drop administration in patients attending and not attending a glaucoma education center. Oman J Ophthalmol. 2016;9:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mcveigh KA, Vakros G. Clinical Ophthalmology Dovepress. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients. 2015;9:813–819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Salyani A, Birt C. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication. Can J Ophthalmol. 2005;40:170–174. [DOI] [PubMed] [Google Scholar]
- 16.Nordmann J-P, Baudouin C, Bron A, et al. Xal-Ease: impact ofan ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction. Eur J Ophthalmol. 2009;19(6):949–956. [DOI] [PubMed] [Google Scholar]
- 17.Strungaru MH, Peck J, Compeau EC, et al. Mirror-hat device as a drop delivery aid: a pilot study. Can J Ophthalmol. 2014;49:333–338. [DOI] [PubMed] [Google Scholar]
- 18.Lazcano-Gomez G, Castillejos A, Kahook M, et al. Video-graphic assessment of glaucoma drop instillation. J Curr Glaucoma Pract. 2015;9:47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Feng A, O’Neill J, Holt M, et al. Success of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations. Clin Ophthalmol. 2016;10:1505–1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122:1308–1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Newman-Casey PA, Niziol LM, Mackenzie CK, et al. Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design. Pilot Feasibility Stud. 2018;4:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yue Z, Li C, Weilin Q, Bin W. Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients. Patient Educ Couns. 2015;98:669–673. [DOI] [PubMed] [Google Scholar]
- 23.Carpenter DM, Blalock SJ, Sayner R, et al. Communication predicts medication self-efficacy in glaucoma patients. Optom Vis Sci. 2016;93:731–737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91–111. [DOI] [PubMed] [Google Scholar]
- 25.Ekong G, Kavookjian J. Motivational interviewing and outcomes in adults with type 2 diabetes: a systematic review. Patient Educ Couns. 2016;99:944–952. [DOI] [PubMed] [Google Scholar]
- 26.Soderlund PD. Effectiveness of motivational interviewing for improving physical activity self-management for adults with type 2 diabetes: a review. Chronic Illn. 2018;14:54–68. [DOI] [PubMed] [Google Scholar]
- 27.Mikkola I, Hagnäs M, Hartsenko J, et al. A personalized care plan is positively associated with better clinical outcomes in the care of patients with type 2 diabetes: a cross-sectional real-life study. Can J Diabetes. 2019;44(2):133–138. [DOI] [PubMed] [Google Scholar]
- 28.Ma C, Zhou Y, Zhou W, Huang C. Evaluation of the effect of motivational interviewing counselling on hypertension care. Patient Educ Couns. 2014;95:231–237. [DOI] [PubMed] [Google Scholar]
- 29.Chang DS, Friedman DS, Frazier T, et al. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications. Ophthalmology. 2013;120: 1396–1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. [DOI] [PubMed] [Google Scholar]
- 31.Robin AL, Novack GD, Covert DW, et al. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144: 533–540. [DOI] [PubMed] [Google Scholar]
- 32.Glaucoma Research Foundation. Eye drop tips. https://www.glaucoma.org/treatment/eyedrop-tips.php; 2020. Accessed XX. XX.XX. [Google Scholar]
- 33.Hennessy AL, Katz J, Covert D, et al. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss. Ophthalmology. 2010;117:2345–2352. [DOI] [PubMed] [Google Scholar]
- 34.Sleath B, Blalock SJ, Stone JL, et al. Validation of a short version of the glaucoma medication self-efficacy questionnaire. Br J Ophthalmol. 2012;96:258–262. [DOI] [PubMed] [Google Scholar]
- 35.Sleath B, Blalock SJ, Robin A, et al. Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations. Eye. 2010;24:624–631. [DOI] [PubMed] [Google Scholar]
- 36.Carpenter DM, Sayner R, Blalock SJ, et al. The effect of eyedrop technique education in patients with glaucoma. Health Commun. 2016;31:1036–1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Davis SA, Carpenter DM, Blalock SJ, et al. A randomized controlled trial of an online educational video intervention to improve glaucoma eye drop technique. Patient Educ Couns. 2019;102:937–943. [DOI] [PubMed] [Google Scholar]
- 38.Cook PF, Schmiege SJ, Mansberger SL, et al. Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med. 2015;49:29–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Dreer LE, Owsley C, Campbell L, et al. Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: “Glaucoma Management Optimism for African Americans Living with Glaucoma” (GOAL). Curr Eye Res. 2015;41:50–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18:401–409. [DOI] [PubMed] [Google Scholar]
- 41.Hennessy AL, Katz J, Covert D, et al. A video study of dropinstillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152:982–988. [DOI] [PubMed] [Google Scholar]
- 42.Sayner R, Carpenter DM, Robin AL, et al. How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique. Int J Pharm Pract. 2016;24:78–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


